- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.04. | Panthera Relocates to Health Innovation Hub | ||
| 08.04. | Frederic Desdouits Appointed CEO of Orano Med | ||
| 08.04. | GSK Wins China Approval for Exdensur in Nasal Polyps | ||
| 08.04. | Vion Biosciences Acquires Cellular Technology Limited | ||
| 07.04. | Veradigm to Appoint Christian Greyenbuhl as Chief Financial Officer | ||
| 07.04. | Valeris Appoints Scott Filosi Chief Commercial Officer | ||
| 07.04. | Biocon Launches Two Denosumab Biosimilars, Aukelso and Bosaya, in US | ||
| 07.04. | BASF Announces Up to 20% Price Increase for Excipients and APIs | ||
| 07.04. | AC Immune, Lilly Amend Morphomer Tau Alliance | ||
| 07.04. | Allucent Expands Specialty CRO Focus Across Oncology, Neuro, CGT | ||
| 07.04. | Gilead Sciences Agrees to Acquire Tubulis | ||
| 07.04. | Halozyme Hypercon, Vertex Pharmaceuticals Enter Exclusive Collab & License Agreement | ||
| 06.04. | GC Biopharma Validates Proprietary Technology to Mitigate Thromboembolic Risks | ||
| 06.04. | Akari Therapeutics Partners with WuXi XDC to Accelerate Development of Novel PH1 Payload | ||
| 06.04. | Thermo Fisher Introduces Gibco CTS Compleo Fill and Finish System | ||
| 06.04. | Scinai Completes Corporate Reorganization Separating CDMO and R&D Operations | ||
| 06.04. | Neurocrine Biosciences Agrees to Acquire Soleno Therapeutics for $2.9B | ||
| 02.04. | CellCarta, Pillar Biosciences Partner to Expand Access to Tumor Profiling | ||
| 02.04. | Merck's Keytruda Approved in EU for Treatment of Recurrent Ovarian Cancers | ||
| 02.04. | PharmaEssentia to Establish New Manufacturing Facility in Puerto Rico | ||
| 02.04. | Lilly to Acquire Centessa Pharmaceuticals | ||
| 01.04. | Korsana Biosciences and Cyclerion Therapeutics to Merge, Operate Under Korsana Name | ||
| 01.04. | Symbiosis Expands Quality Control Lab | ||
| 01.04. | ROIS Expands U.S. Footprint with Acquisition of Phoenix Manufacturing Site | ||
| 01.04. | Neuland Laboratories Names Saharsh Davuluri as CEO and Managing Director |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.